Formula Growth’s Celgene Corp CELG Stock Holding History

Formula Growth’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-12,000	Closed	-$1.07M	–	167
2018 Q1	$1.07M	Hold	12,000	–	–	0.13%	131
2017 Q4	$1.25M	Sell	12,000 -2,000	-14%	-$226K	0.16%	107
2017 Q3	$2.04M	Sell	14,000 -2,000	-13%	-$272K	0.32%	73
2017 Q2	$2.08M	Sell	16,000 -2,000	-11%	-$245K	0.36%	72
2017 Q1	$2.24M	Hold	18,000	–	–	0.47%	59
2016 Q4	$2.08M	Hold	18,000	–	–	0.48%	65
2016 Q3	$1.88M	Hold	18,000	–	–	0.43%	81
2016 Q2	$1.77M	Hold	18,000	–	–	0.43%	77
2016 Q1	$1.8M	Hold	18,000	–	–	0.43%	82
2015 Q4	$2.16M	Buy	+18,000	New	+$2.08M	0.5%	68

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Formula Growth's CELG Position: Q2 2018 in Review

Formula Growth sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 12,000 shares — an estimated $1.07M sold.

Formula Growth first reported a position in CELG in Q4 2015 and held it in 10 quarters. The position peaked at $2.24M in Q1 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

Formula Growth reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
Formula Growth sold 12,000 Celgene Corp shares in Q2 2018, an estimated $1.07M.
Formula Growth first reported a position in Celgene Corp in Q4 2015 and held it in 10 quarters.
Formula Growth's Celgene Corp position peaked at $2.24M in Q1 2017.
1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Formula Growth's 13F filing for Q2 2018, filed 13 Aug 2018.